Cubist Systematic Strategies’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.73M Buy
+123,900
New +$2.68M 0.02% 1158
2024
Q3
Sell
-39,600
Closed -$442K 2925
2024
Q2
$442K Buy
39,600
+3,200
+9% +$37.3K ﹤0.01% 2186
2024
Q1
$451K Sell
36,400
-58,000
-61% -$967K ﹤0.01% 2668
2023
Q4
$2.5M Buy
94,400
+13,100
+16% +$382K 0.02% 1349
2023
Q3
$3.72M Sell
81,300
-25,000
-24% -$1.16M 0.03% 946
2023
Q2
$4.38M Sell
106,300
-800
-0.7% -$26.2K 0.03% 930
2023
Q1
$3.32M Buy
107,100
+62,700
+141% +$2.02M 0.02% 1264
2022
Q4
$892K Buy
+44,400
New +$950K 0.01% 2563

Other funds holding AEHR

Cubist Systematic Strategies's AEHR Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Aehr Test Systems (AEHR) in Q2 2024, closing a stake of 20,329 shares — an estimated $237K sold.

Cubist Systematic Strategies first reported a position in AEHR in Q3 2021 and held it in 9 quarters. The position peaked at $2.34M in Q4 2022. 119 funds tracked by Wall St. Rank hold AEHR as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Aehr Test Systems position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 20,329 Aehr Test Systems shares in Q2 2024, an estimated $237K.
  • Cubist Systematic Strategies first reported a position in Aehr Test Systems in Q3 2021 and held it in 9 quarters.
  • Cubist Systematic Strategies's Aehr Test Systems position peaked at $2.34M in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.